GPT Healthcare Limited
GPT Healthcare Limited (GPTHEALTH) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Healthcare Services›Hospital
gptgroup.co.in(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
|---|---|---|---|---|
| Sales | 101 Cr | 107 Cr | 119 Cr | 120 Cr |
| Operating expenses (approx.) | 81 Cr | 90 Cr | 96 Cr | 99 Cr |
| EBITDA | 21 Cr | 17 Cr | 23 Cr | 21 Cr |
| OPM % | 20.4% | 16.2% | 19.1% | 17.2% |
| Other income | 2 Cr | 2 Cr | 1 Cr | 1 Cr |
| Interest | 1 Cr | 2 Cr | 2 Cr | 2 Cr |
| Depreciation | 5 Cr | 6 Cr | 7 Cr | 7 Cr |
| Profit before tax | 16 Cr | 11 Cr | 15 Cr | 13 Cr |
| Tax % | 21.3% | 30.9% | 29.6% | 26.6% |
| Net profit | 13 Cr | 8 Cr | 11 Cr | 9 Cr |
| EPS (₹) | ₹1.57 | ₹0.94 | ₹1.29 | ₹1.14 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | TTM |
|---|---|---|
| Sales | 407 Cr | Sign in for TTM |
| Operating expenses (approx.) | 324 Cr | Sign in for TTM |
| EBITDA | 83 Cr | Sign in for TTM |
| OPM % | 20.5% | Sign in for TTM |
| Other income | 8 Cr | Sign in for TTM |
| Interest | 3 Cr | Sign in for TTM |
| Depreciation | 19 Cr | Sign in for TTM |
| Profit before tax | 69 Cr | Sign in for TTM |
| Tax % | 28.0% | Sign in for TTM |
| Net profit | 50 Cr | Sign in for TTM |
| EPS (₹) | ₹6.08 | Sign in for TTM |
| Dividend payout % | 57.5% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 |
|---|---|
| Equity capital | 82 Cr |
| Reserves | 166 Cr |
| Borrowings | 13 Cr |
| Other liabilities | 123 Cr |
| Total liabilities | 384 Cr |
| Fixed assets (net) | 203 Cr |
| CWIP | 46 Cr |
| Investments | 32 Cr |
| Loans & advances | 0.17 Cr |
| Inventories | 9 Cr |
| Trade receivables | 25 Cr |
| Cash & bank | 2 Cr |
| Other assets | 68 Cr |
| Total assets | 384 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 |
|---|---|
| Cash from operating activity | 67 Cr |
| Cash from investing | -33 Cr |
| Cash from financing | -35 Cr |
| Net cash flow | -0.03 Cr |
| Free cash flow (OCF − Capex) | 17 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2025 |
|---|---|
| ROCE % | 27.9% |
| ROE % | 20.1% |
| Debtor days | 22 |
| Inventory days | 41 |
| Days payable | 161 |
| Cash conversion cycle | -98 |
| Debt / equity | 0.05 |
| Current ratio | 1.06 |
| Net debt / EBITDA | 0.14 |
Compare with peers
Loading peers…